14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with 12-hydroxy-5,8,10,14-eicosatetraenoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, WB; Falck, JR; Pfister, SL | 1 |
| Lei, J; Li, Y; Wang, T; Wang, X; Wu, L; Yan, G; Ye, D; Zhang, Q; Zhang, X; Zhou, Y | 1 |
2 other study(ies) available for 14,15-epoxy-5,8,11-eicosatrienoic acid and 12-hydroxy-5,8,10,14-eicosatetraenoic acid
| Article | Year |
|---|---|
Enhanced synthesis of epoxyeicosatrienoic acids by cholesterol-fed rabbit aorta.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; 6-Ketoprostaglandin F1 alpha; 8,11,14-Eicosatrienoic Acid; Animals; Aorta, Thoracic; Arachidonic Acids; Carbon Radioisotopes; Cholesterol, Dietary; Clotrimazole; Diet, Atherogenic; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Indomethacin; Kinetics; Masoprocol; Metyrapone; Muscle, Smooth, Vascular; Rabbits; Reference Values; Stereoisomerism | 1991 |
Anti- Versus Pro-Inflammatory Metabololipidome Upon Cupping Treatment.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 8,11,14-Eicosatrienoic Acid; Animals; Bone Marrow Cells; Cells, Cultured; Fatty Acids, Unsaturated; Hematoma; Interleukin-6; Lipids; Lipopolysaccharides; Macrophages; Male; Metabolome; Mice; Mice, Inbred C57BL; Mice, Nude; RAW 264.7 Cells; Skin; Thromboxane B2; Tumor Necrosis Factor-alpha; Up-Regulation | 2018 |